|
BAZ2A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.197200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.813400E-01 |
| Normal-vs-Stage2 |
3.159600E-01 |
| Normal-vs-Stage3 |
2.147400E-01 |
| Normal-vs-Stage4 |
9.349800E-01 |
| Stage1-vs-Stage2 |
1.537970E-01 |
| Stage1-vs-Stage3 |
4.481700E-02 |
| Stage1-vs-Stage4 |
6.082600E-01 |
| Stage2-vs-Stage3 |
9.950000E-01 |
| Stage2-vs-Stage4 |
3.480800E-01 |
| Stage3-vs-Stage4 |
2.501200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.140600E-01 |
| Normal-vs-AfricanAmerican |
2.062200E-01 |
| Normal-vs-Asian |
5.666000E-01 |
| Caucasian-vs-AfricanAmerican |
2.546200E-01 |
| Caucasian-vs-Asian |
4.348000E-01 |
| AfricanAmerican-vs-Asian |
4.296000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.986200E-01 |
| Normal-vs-Female |
9.716600E-01 |
| Male-vs-Female |
3.825800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.929400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.602200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.372400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.219900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.014600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.962100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.863500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.707800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.668200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.469580E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.064280E-03 |
| Classical-VS-Follicular |
2.606200E-02 |
| Classical-VS-Other |
1.914440E-01 |
| Classical-VS-Normal |
3.199200E-01 |
| Tall-VS-Follicular |
8.683600E-01 |
| Tall-VS-Other |
9.189200E-01 |
| Tall-VS-Normal |
7.144000E-02 |
| Follicular-VS-Other |
9.833600E-01 |
| Follicular-VS-Normal |
1.830440E-01 |
| Other-VS-Normal |
3.614600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.422600E-01 |
| Normal-vs-N1 |
9.208000E-01 |
| N0-vs-N1 |
3.697800E-01 |
|
|
